Back
Arbutus Biopharma Corp. Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
36
ABUS
Arbutus Biopharma Corp.
Last Price:
$4.13
Seasonality Move:
0.11%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.
Arbutus Biopharma Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.13 | Buy |
| 20-day SMA: | 4.48 | Sell |
| 50-day SMA: | 4.49 | Sell |
| 200-day SMA: | 3.91 | Buy |
| 8-day EMA: | 4.2 | Sell |
| 20-day EMA: | 4.37 | Sell |
| 50-day EMA: | 4.45 | Sell |
| 200-day EMA: | 4.08 | Buy |
Arbutus Biopharma Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 40.37 | Sell |
| Chaikin Money Flow: | -161776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.24 - 4.82) | Sell |
| Bollinger Bands (100): | (4.27 - 4.69) | Sell |
Arbutus Biopharma Corp. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arbutus Biopharma Corp. Stock
Is Arbutus Biopharma Corp. Stock a Buy?
-
Arbutus Biopharma Corp. share price is 4.14 while ABUS 8-day simple moving average is 4.13, which is a Buy signal.
-
The stock price of ABUS is 4.14 while Arbutus Biopharma Corp. 20-day SMA is 4.48, which makes it a Sell.
-
Arbutus Biopharma Corp. 50-day simple moving average is 4.49 while ABUS share price is 4.14, making it a Sell technically.
-
ABUS stock price is 4.14 and Arbutus Biopharma Corp. 200-day simple moving average is 3.91, creating a Buy signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
36
Arbutus Biopharma Corp. (ABUS)
is a Sell
Is Arbutus Biopharma Corp. a Buy or a Sell?
-
Arbutus Biopharma Corp. stock is rated a SellThe current Arbutus Biopharma Corp. [ABUS] share price is $4.14. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Corp. Stock Info
Market Cap:
790.5M
Price in USD:
4.14
Share Volume:
1.2M
Arbutus Biopharma Corp. 52-Week Range
52-Week High:
5.10
52-Week Low:
2.71
Sell
36
Arbutus Biopharma Corp. (ABUS)
is a Sell
Arbutus Biopharma Corp. Share Price Forecast
-
What is the Arbutus Biopharma Corp. stock price today?The Arbutus Biopharma Corp. stock price is 4.14 USD today.
-
Will ABUS stock go up or go down?Arbutus Biopharma Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is Arbutus Biopharma Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma Corp. is overvalued.
Is Arbutus Biopharma Corp. Stock a Buy?
-
Arbutus Biopharma Corp. share price is 4.14 while ABUS 8-day exponential moving average is 4.20, which is a Sell signal.
-
The stock price of ABUS is 4.14 while Arbutus Biopharma Corp. 20-day EMA is 4.37, which makes it a Sell.
-
Arbutus Biopharma Corp. 50-day exponential moving average is 4.45 while ABUS share price is 4.14, making it a Sell technically.
-
ABUS stock price is 4.14 and Arbutus Biopharma Corp. 200-day simple moving average is 4.08, creating a Buy signal.
Fundamental Analysis of Arbutus Biopharma Corp.
Is Arbutus Biopharma Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Arbutus Biopharma Corp.
Should I short Arbutus Biopharma Corp. stock?
-
ABUS Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Arbutus Biopharma Corp. is a Sell
-
Arbutus Biopharma Corp. Relative Strength Index (RSI) is 40.37, which suggest Arbutus Biopharma Corp. is oversold
-
The Bollinger Bands (25) for Arbutus Biopharma Corp. is (4.24 - 4.82), which suggest Arbutus Biopharma Corp. is a Sell
-
The Bollinger Bands (100) for Arbutus Biopharma Corp. is (4.27 - 4.69), which suggest Arbutus Biopharma Corp. is a Sell
* Arbutus Biopharma Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.